A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients

NCT00000699 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Inosine pranobex
DRUG: Ribavirin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)